middle.news
Entropy Neurodynamics Files US Patent Backed by 75% IBS Response Rate
10:14am on Tuesday 5th of May, 2026 AEST
•
Biotechnology
Read Story
Entropy Neurodynamics Files US Patent Backed by 75% IBS Response Rate
10:14am on Tuesday 5th of May, 2026 AEST
Key Points
New US provisional patent filed for TRP-8803 IBS therapy
Phase 2a trial shows 75% response rate in treatment-resistant IBS
Patent complements existing international and Australian filings
Supports US-focused development and partnering strategy
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Entropy Neurodynamics (ASX:ENP)
OPEN ARTICLE